LIGHTPOINT
LIVE

Serial Number

79405616

Owner

Telix Pharmaceuticals Limited

Attorney

Andrew S. Ehard

Filing Date

May 14, 2024

Add to watchlist:

No watchlists yet
View on USPTO

LIGHTPOINT Trademark

Serial Number: 79405616

LIGHTPOINT is a trademark filed by Telix Pharmaceuticals Limited on May 14, 2024. The trademark is classified under Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Telix Pharmaceuticals Limited (38 trademarks)

Suite 401, 55 Flemington Road

Entity Type: 99

Trademark Details

Filing Date

May 14, 2024

Registration Date

Not Registered

Goods & Services

Diagnostic apparatus for the detection of cancer; medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; medical apparatus and instruments for diagnostic radiopharmaceutical use; medical devices for detecting and treating cancer.

Filing History

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 28, 2026 RCCK
NEW REPRESENTATIVE AT IB RECEIVED
Jan 22, 2026 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jan 1, 2026 NREP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 7, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 7, 2025 GNSL
SUSPENSION LETTER WRITTEN
Jul 7, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 20, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 20, 2025 ERSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 16, 2025 RCSC
REFUSAL PROCESSED BY IB
Jan 5, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 15, 2024 RFCS
REFUSAL PROCESSED BY MPU
Dec 15, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 3, 2024 RFCR
SUSPENSION LETTER WRITTEN
Dec 2, 2024 CNSL
ASSIGNED TO EXAMINER
Nov 26, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 16, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 16, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 7, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 3, 2024 REPR